Dataset Information


Musashi-1 promotes stress-induced tumor progression through recruitment of AGO2.

ABSTRACT: Carcinomatous progression and recurrence are the main therapeutic challenges frequently faced by patients with refractory tumors. However, the underlined molecular mechanism remains obscure.Methods: We found Musashi-1 (MSI1) transported into cytosol under stress condition by confocal microscopy and cell fractionation. Argonaute 2 (AGO2) was then identified as a cytosolic binding partner of MSI1 by Mass Spectrametry, immunoprecipitation, and recombinant protein pull-down assay. We used RNA-IP to determine the MSI1/AGO2 associated regions on downstream target mRNAs. Finally, we overexpressed C-terminus of MSI1 to disrupt endogenous MSI1/AGO2 interaction and confirm it effects on tmor progression.Results: Malignant tumors exhibit elevated level of cytosolic Musashi-1 (MSI1), which translocates into cytosol in response to stress and promote tumor progression. Cytosolic MSI1 forms a complex with AGO2 and stabilize or destabilize its target mRNAs by respectively binding to their 3´ untranslated region or coding domain sequence. Both MSI1 translocation and MSI1/AGO2 binding are essential for promoting tumor progression. Blocking MSI1 shuttling by either chemical inhibition or point mutation attenuates the growth of GBM-xenografts in mice. Importantly, overexpression of the C-terminus of MSI1 disrupts endogenous MSI1/AGO2 interaction and effectively reduces stress-induced tumor progression.Conclusion: Our findings highlight novel molecular functions of MSI1 during stress-induced carcinomatous recurrence, and suggest a new therapeutic strategy for refractory malignancies by targeting MSI1 translocation and its interaction with AGOs.


PROVIDER: S-EPMC6929620 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7463734 | BioStudies
1000-01-01 | S-EPMC6203984 | BioStudies
2020-01-01 | S-EPMC7079100 | BioStudies
2017-01-01 | S-EPMC5413399 | BioStudies
2014-01-01 | S-EPMC4094780 | BioStudies
2017-01-01 | S-EPMC5739758 | BioStudies
1000-01-01 | S-EPMC3822633 | BioStudies
1000-01-01 | S-EPMC4494958 | BioStudies
2017-01-01 | S-EPMC5798584 | BioStudies
1000-01-01 | S-EPMC4598749 | BioStudies